News
Home/ News
(Filtering posts by category: Patents) - Remove filter
Broad patent claims can be valuable, but only if the specification can support them. A recent Australian Patent Office decision is a reminder that describing the desired result is not enough. Applicants also need to explain, with sufficient technical substance, how that result can actually be achieved.
A clinical trial protocol can create patent problems before any results are published. Updated IP Australia guidance highlights why pharmaceutical, biotech and medical technology businesses should consider patent protection before proposed treatments or research plans are made public.
Patent attorneys work at the intersection of technology, science, business and law. Their role is not just to file patent applications, but to understand how an invention works, assess what may be new, draft protection carefully and help businesses decide whether a patent makes commercial sense.
A provisional patent application can be a useful first step in protecting an invention, but it is not a patent in itself. Its value depends on what is filed on day one, particularly whether the invention is described clearly enough to support an early priority date and future patent protection.
Having a patent does not necessarily mean you are free to commercialise your product. A freedom to operate search looks for existing patent rights that could create infringement risk before launch, manufacture or market entry. Identifying those risks early can help businesses avoid costly surprises and make better commercial decisions.
If your business exports pharmaceutical products to Malaysia, licenses technology there, or is watching the region for growth opportunities, a regulatory change currently taking shape in Kuala Lumpur is worth your attention.
“Patent pending” does not mean a patent has been granted. However, a well-drafted pending patent application can still have real commercial value. It can create uncertainty for competitors, support investor confidence and help a business protect its position before the patent is granted.
Artificial intelligence is no longer a future concept in the pharmaceutical sector. It is already reshaping how new drugs are discovered, designed, tested and manufactured — and that shift is creating major opportunities for businesses working in life sciences, biotech and medical innovation.
The World Intellectual Property Report 2026 has a simple message: technology is spreading faster than ever — and the advantage now goes to the businesses that can adopt, adapt, and protect faster than their competitors.
